171 related articles for article (PubMed ID: 15635283)
1. [High throughput screening of pharmacokinetics and metabolism in drug discovery (I)--establishment of assessment system for absorption to compounds with a wide diversity of physical properties].
Komura H; Kawahara I; Shigemoto Y; Matsuda K; Ano R; Murayama Y; Moriwaki T; Yoshida NH
Yakugaku Zasshi; 2005 Jan; 125(1):121-30. PubMed ID: 15635283
[TBL] [Abstract][Full Text] [Related]
2. [High throughput screening of pharmacokinetics and metabolism in drug discovery (II)--investigation on in vitro and in vivo correlation in drug metabolism screening].
Komura H; Matsuda K; Shigemoto Y; Kawahara I; Ano R; Murayama Y; Moriwaki T; Yoshida NH
Yakugaku Zasshi; 2005 Jan; 125(1):131-9. PubMed ID: 15635284
[TBL] [Abstract][Full Text] [Related]
3. [High throughput screening of pharmacokinetics and metabolism in drug discovery (III)--investigation on in- silico model for membrane permeability and CYP1A2 inhibition].
Komura H; Shigemoto Y; Kawahara I; Matsuda K; Ano R; Murayama Y; Moriwaki T; Yoshida NH
Yakugaku Zasshi; 2005 Jan; 125(1):141-7. PubMed ID: 15635285
[TBL] [Abstract][Full Text] [Related]
4. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
5. Development of a high throughput equilibrium solubility assay using miniaturized shake-flask method in early drug discovery.
Zhou L; Yang L; Tilton S; Wang J
J Pharm Sci; 2007 Nov; 96(11):3052-71. PubMed ID: 17722003
[TBL] [Abstract][Full Text] [Related]
6. A high throughput solubility assay for drug discovery using microscale shake-flask and rapid UHPLC-UV-CLND quantification.
Lin B; Pease JH
J Pharm Biomed Anal; 2016 Apr; 122():126-40. PubMed ID: 26855285
[TBL] [Abstract][Full Text] [Related]
7. Prediction of human pharmacokinetics--gastrointestinal absorption.
Fagerholm U
J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
[TBL] [Abstract][Full Text] [Related]
8. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics.
Roberts SA
Xenobiotica; 2001; 31(8-9):557-89. PubMed ID: 11569526
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a method for high throughput solubility determination using a multi-wavelength UV plate reader.
Chen TM; Shen H; Zhu C
Comb Chem High Throughput Screen; 2002 Nov; 5(7):575-81. PubMed ID: 12470271
[TBL] [Abstract][Full Text] [Related]
10. Preclinical dose number and its application in understanding drug absorption risk and formulation design for preclinical species.
Wuelfing WP; Daublain P; Kesisoglou F; Templeton A; McGregor C
Mol Pharm; 2015 Apr; 12(4):1031-9. PubMed ID: 25671350
[TBL] [Abstract][Full Text] [Related]
11. Volume to dissolve applied dose (VDAD) and apparent dissolution rate (ADR): tools to predict in vivo bioavailability from orally applied drug suspensions.
Muenster U; Pelzetter C; Backensfeld T; Ohm A; Kuhlmann T; Mueller H; Lustig K; Keldenich J; Greschat S; Göller AH; Gnoth MJ
Eur J Pharm Biopharm; 2011 Aug; 78(3):522-30. PubMed ID: 21315152
[TBL] [Abstract][Full Text] [Related]
12. Chemiluminescent nitrogen detection (CLND) to measure kinetic aqueous solubility.
Kestranek A; Chervenak A; Longenberger J; Placko S
Curr Protoc Chem Biol; 2013; 5(4):269-80. PubMed ID: 24391097
[TBL] [Abstract][Full Text] [Related]
13. [Development of solubility screening methods in drug discovery].
Sugaya Y; Yoshiba T; Kajima T; Ishihama Y
Yakugaku Zasshi; 2002 Mar; 122(3):237-46. PubMed ID: 11905048
[TBL] [Abstract][Full Text] [Related]
14. High throughput UV method for the estimation of thermodynamic solubility and the determination of the solubility in biorelevant media.
Bard B; Martel S; Carrupt PA
Eur J Pharm Sci; 2008 Mar; 33(3):230-40. PubMed ID: 18207706
[TBL] [Abstract][Full Text] [Related]
15. Addition of Optimized Bovine Serum Albumin Level in a High-Throughput Caco-2 Assay Enabled Accurate Permeability Assessment for Lipophilic Compounds.
Cai X; Madari S; Walker A; Paiva A; Li Y; Herbst J; Shou W; Weller H
SLAS Discov; 2019 Aug; 24(7):738-744. PubMed ID: 31076010
[TBL] [Abstract][Full Text] [Related]
16. In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.
Sun D; Yu LX; Hussain MA; Wall DA; Smith RL; Amidon GL
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):75-85. PubMed ID: 14982151
[TBL] [Abstract][Full Text] [Related]
17. Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I-IV.
Taub ME; Kristensen L; Frokjaer S
Eur J Pharm Sci; 2002 May; 15(4):331-40. PubMed ID: 11988394
[TBL] [Abstract][Full Text] [Related]
18. [Physico-chemical profiling of centrally acting molecules for prediction of pharmacokinetic properties].
Deák K
Acta Pharm Hung; 2008; 78(3):110-20. PubMed ID: 18986088
[TBL] [Abstract][Full Text] [Related]
19. High throughput screening of physicochemical properties and in vitro ADME profiling in drug discovery.
Wan H; Holmén AG
Comb Chem High Throughput Screen; 2009 Mar; 12(3):315-29. PubMed ID: 19275537
[TBL] [Abstract][Full Text] [Related]
20. In silico approaches to prediction of aqueous and DMSO solubility of drug-like compounds: trends, problems and solutions.
Balakin KV; Savchuk NP; Tetko IV
Curr Med Chem; 2006; 13(2):223-41. PubMed ID: 16472214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
